PM
62
2
HAS
42
-6
SWN
42
-4
FITB
50
-2
TGT
43
-2
PVH
59
-5
EMR
48
-3
VMC
54
-2
MA
67
-2
SYF
88
-2
MAS
47
-4
SE
41
-5
KLAC
65
4
NTAP
67
2
VFC
57
-5
TXT
72
-3
KSS
52
-2
AMGN
52
-5
MS
62
-2
HOG
30
-3
PM
62
2
HAS
42
-6
SWN
42
-4
FITB
50
-2
TGT
43
-2
PVH
59
-5
EMR
48
-3
VMC
54
-2
MA
67
-2
SYF
88
-2
MAS
47
-4
SE
41
-5
KLAC
65
4
NTAP
67
2
VFC
57
-5
TXT
72
-3
KSS
52
-2
AMGN
52
-5
MS
62
-2
HOG
30
-3
Financhill
Back

Citizens Financial Group Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
46

CFG
Citizens Financial Group

Last Price:
34.99
Seasonality Move:
0.75%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
46
Citizens Financial Group (CFG) is a Sell

Is Citizens Financial Group a Buy, Sell or Hold?

  • The current Citizens Financial Group [CFG] share price is $34.99. The Score for CFG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CFG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CFG Stock Price Chart

What is Citizens Financial Group's stock price today?

  • The Citizens Financial Group share price today is $34.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CFG is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

CFG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 51.54 Buy
Chaikin Money Flow: -3421464 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.12 - 35.52) Buy
Bollinger Bands (100): (32.34 - 35.68) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

CFG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.71 Buy
20-day SMA: 34.55 Buy
50-day SMA: 34.95 Buy
200-day SMA: 31.31 Buy
8-day EMA: 34.82 Buy
20-day EMA: 34.8 Buy
50-day EMA: 34.72 Buy
200-day EMA: 32.86 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Citizens Financial Group Earnings Growth & CFG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.62 per share, and an increase next year of $0.79 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Citizens Financial Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):